MX2022005143A - Sistemas de ensayo de flujo lateral y métodos para la cuantificación de una muestra biológica. - Google Patents

Sistemas de ensayo de flujo lateral y métodos para la cuantificación de una muestra biológica.

Info

Publication number
MX2022005143A
MX2022005143A MX2022005143A MX2022005143A MX2022005143A MX 2022005143 A MX2022005143 A MX 2022005143A MX 2022005143 A MX2022005143 A MX 2022005143A MX 2022005143 A MX2022005143 A MX 2022005143A MX 2022005143 A MX2022005143 A MX 2022005143A
Authority
MX
Mexico
Prior art keywords
methods
lateral flow
flow assay
quantification
biological sample
Prior art date
Application number
MX2022005143A
Other languages
English (en)
Inventor
Patrick Lawless
Original Assignee
Sanguis Diagnostics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanguis Diagnostics Corp filed Critical Sanguis Diagnostics Corp
Publication of MX2022005143A publication Critical patent/MX2022005143A/es

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54386Analytical elements
    • G01N33/54387Immunochromatographic test strips
    • G01N33/54388Immunochromatographic test strips based on lateral flow
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/84Systems specially adapted for particular applications
    • G01N21/8483Investigating reagent band
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5302Apparatus specially adapted for immunological test procedures
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54386Analytical elements
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575Hormones
    • G01N2333/62Insulins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/042Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54346Nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

En la presente se describen dispositivos y métodos para probar la resistencia a la insulina, desregulación de la insulina, hiperinsulinemia y Síndrome Metabólico Equino (EMS) en sujetos equinos utilizando un ensayo de flujo lateral único que proporciona determinaciones cuantitativas o semicuantitativas de las concentraciones de insulina en sangre completa, plasma y/o suero recolectado de los sujetos equinos.
MX2022005143A 2019-10-30 2020-10-28 Sistemas de ensayo de flujo lateral y métodos para la cuantificación de una muestra biológica. MX2022005143A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962927910P 2019-10-30 2019-10-30
PCT/US2020/057636 WO2021086900A1 (en) 2019-10-30 2020-10-28 Lateral flow assay systems and methods for the quantification of a biological sample

Publications (1)

Publication Number Publication Date
MX2022005143A true MX2022005143A (es) 2022-09-19

Family

ID=75715574

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022005143A MX2022005143A (es) 2019-10-30 2020-10-28 Sistemas de ensayo de flujo lateral y métodos para la cuantificación de una muestra biológica.

Country Status (10)

Country Link
US (1) US20210263026A1 (es)
EP (1) EP4052019A4 (es)
JP (1) JP2023501164A (es)
CN (1) CN114846317A (es)
AU (1) AU2020376805A1 (es)
BR (1) BR112022008391A2 (es)
CA (1) CA3156425A1 (es)
CL (1) CL2022001084A1 (es)
MX (1) MX2022005143A (es)
WO (1) WO2021086900A1 (es)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6267722B1 (en) * 1998-02-03 2001-07-31 Adeza Biomedical Corporation Point of care diagnostic systems
ATE479096T1 (de) * 2004-07-29 2010-09-15 Relia Diagnostic Systems Llc Querstromsystem und assay
NL1027737C2 (nl) * 2004-12-14 2006-06-16 Teststrip B V Chromatografische analyse-inrichting en test kit.
EP2215450B1 (en) * 2006-02-21 2013-07-31 Nexus DX, Inc. Methods and compositions for analyte detection
CN102323422B (zh) * 2011-05-30 2014-03-12 中国科学院上海微系统与信息技术研究所 半定量同时检测cTnI和Myo的免疫层析试纸条及其制备
US20160282343A1 (en) * 2012-08-15 2016-09-29 Immunolab LLC Quantitative lateral flow assay strips for quantitative analysis of an analyte, kits containing such strips and methods of manufacture and use of same
EP3311142B1 (en) * 2015-06-18 2020-09-16 NSPC Technologies, LLC Detection of cerebrospinal fluid

Also Published As

Publication number Publication date
US20210263026A1 (en) 2021-08-26
AU2020376805A1 (en) 2022-06-16
WO2021086900A1 (en) 2021-05-06
BR112022008391A2 (pt) 2022-07-12
EP4052019A4 (en) 2023-12-06
JP2023501164A (ja) 2023-01-18
CN114846317A (zh) 2022-08-02
CL2022001084A1 (es) 2023-01-20
CA3156425A1 (en) 2021-05-06
EP4052019A1 (en) 2022-09-07

Similar Documents

Publication Publication Date Title
DK1766400T3 (da) Fremgangsmåde til at udföre fuldblodsanalyser
MX2021003771A (es) Analisis de analitos multiples usando un ensayo unico.
Antunes et al. Ultra-high performance liquid chromatography tandem mass spectrometric method for the determination of tamoxifen, N-desmethyltamoxifen, 4-hydroxytamoxifen and endoxifen in dried blood spots—development, validation and clinical application during breast cancer adjuvant therapy
MY192493A (en) Urinalysis device and dry reagent for quantitative urinalysis
MX361882B (es) Deteccion en tiempo real de virus de influenza.
WO2009146450A3 (en) Methods for monitoring immunosuppressant drug levels, renal function, and hepatic function using small volume samples
DK1644737T3 (da) Indretning og fremgangsmåde til simultan udförelse af blodgruppebestemmelse, serum-kontrapröve og anti-stofsögningstest
MX2013004305A (es) Metodos para determinar isotipos de anticuerpos anti-farmacos.
MX2019011775A (es) Metodos para la cuantificacion de insulina y peptido c.
MX340547B (es) Equipos de prueba de diagnostico.
EP1978361A3 (en) Method for performing correction of blood glucose assay bias using blood hemoglobin concentration as determined by a glucose-hemoglobin A1C combination system and devices for same
BRPI0407299A (pt) Métodos para detectar um analito associado com o hiv, para determinar a relação de células t cd4+ para células t cd8+, e para detectar rna do hiv, em uma amostra de sangue
WO2003106964A3 (en) HIGH EFFICIENCY METHODS AND DEVICES FOR ASSAYING ANALYTES IN A FLUID SAMPLE
MX2020000186A (es) Ensayos para evaluar los niveles de anticuerpos neutralizantes en sujetos tratados con un fármaco biológico y usos de los mismos en medicina personalizada.
BRPI0811536B8 (pt) método para detectar uma cetona biologicamente ativa e método para extração
Every Detection of ethylglucuronide in urine following the application of Germ-X
WO2012151105A3 (en) Basophil analysis system and method
GB2528657A8 (en) Sample analysing device
MX2020010315A (es) Ensayos sandwich de colocalizacion por enlace.
MX2020006728A (es) Metodos para medir analito y/o proteina en muestras biologicas.
Avery et al. The male genital tract is not a pharmacological sanctuary from efavirenz
ATE525657T1 (de) Analytisches einweg-mikroprozessorgerät
BR112018010764A2 (pt) método para detectar atividade bacteriana em uma amostra biológica e unidade de detecção correspondente
EP3736571A4 (en) METHOD, REAGENT AND CHIP FOR MEASURING THE ANALYTE CONCENTRATION IN A BIOLOGICAL SAMPLE
Brasier et al. Non-invasive drug monitoring of β-lactam antibiotics using sweat analysis—a pilot study